Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer

G. Sette, V. Salvati, M. Mottolese, P. Visca, E. Gallo, K. Fecchi, E. Pilozzi, E. Duranti, E. Policicchio, M. Tartaglia, M. Milella, R. De Maria, A. Eramo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences